Prism MarketView

December 12, 2024 at 8:15 am

Aditxt’s Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials

Submission for Regulatory Approval to Initiate Human Trials for Type 1 Diabetes, Psoriasis, and Stiff-Person Syndrome Targeted for H2 2025 MOUNTAIN VIEW, Calif., December 12,… [Read More]

December 11, 2024 at 9:15 am

Healthy Returns: A huge deal to boost Novo Nordisk’s manufacturing is one step closer to closing

A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little… [Read More]

December 11, 2024 at 8:00 am

NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement

Extends Relationship with Ultra Pain Products, Inc for Distribution of PainShield for Five Years ELMSFORD, N.Y., December 11, 2024–(BUSINESS WIRE)–NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”),… [Read More]

December 05, 2024 at 10:09 am

UnitedHealthcare CEO Brian Thompson fatally shot in targeted attack, gunman still at large

Brian Thompson, the CEO of UnitedHealth Group’s insurance unit, was fatally shot outside the Hilton hotel in midtown Manhattan on Wednesday morning, in what appears… [Read More]

December 05, 2024 at 10:09 am

UnitedHealthcare CEO Brian Thompson fatally shot in targeted attack, gunman still at large

Brian Thompson, the CEO of UnitedHealth Group’s insurance unit, was fatally shot outside the Hilton hotel in midtown Manhattan on Wednesday morning, in what appears… [Read More]

December 05, 2024 at 9:48 am

Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data

The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images A version of this… [Read More]

December 05, 2024 at 9:48 am

Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data

The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images A version of this… [Read More]

December 05, 2024 at 9:00 am

Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says

Prescription fills for blockbuster weight loss medications in the U.S. more than doubled in 2024, even with limited insurance coverage and high out-of-pocket costs for… [Read More]

December 04, 2024 at 2:04 pm

Eli Lilly’s obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

New trial data has cemented Club holding Eli Lilly ‘s pole position in the highly competitive obesity drug race. The news Eli Lilly’s obesity drug… [Read More]

December 04, 2024 at 2:04 pm

Eli Lilly’s obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

New trial data has cemented Club holding Eli Lilly ‘s pole position in the highly competitive obesity drug race. The news Eli Lilly’s obesity drug… [Read More]

December 04, 2024 at 11:50 am

Our newest portfolio stock backed off its recent 52-week high — so we’re buying more

We’re buying 300 shares of Bristol-Myers Squibb at roughly $58 each. Following Wednesday’s trade, Jim Cramer’s Charitable Trust will own 800 shares of BMY, increasing… [Read More]

December 04, 2024 at 11:50 am

Our newest portfolio stock backed off its recent 52-week high — so we’re buying more

We’re buying 300 shares of Bristol-Myers Squibb at roughly $58 each. Following Wednesday’s trade, Jim Cramer’s Charitable Trust will own 800 shares of BMY, increasing… [Read More]

Feed Category: Healthcare